Rozulip (rozuvastatin) coated tablets 20 mg. №28

$36.00

Manufacturer: Hungary

Purpose: Lowers cholesterol levels by inhibiting HMG-CoA reductase enzyme.

SKU: MED61110 Category:

Description

Rozulip (Rozuvastatin) Coated Tablets 20 mg. №28

Ingredients:

  • Each tablet contains 20 mg of rozuvastatin.

Dosage:

  • The usual dose is 20 mg once daily.
  • Dosage may vary based on individual patient needs and medical condition.

Indications:

  • Rozulip tablets are indicated for the treatment of high cholesterol and triglycerides.
  • Used to reduce the risk of heart attack, stroke, and other heart complications in patients with cardiovascular diseases.

Contraindications:

  • Do not use Rozulip if you are pregnant, breastfeeding, or have liver disease.
  • Consult your healthcare provider before starting this medication.

Directions:

  • Take Rozulip exactly as prescribed by your doctor.
  • Swallow the tablet whole with a glass of water.
  • It can be taken with or without food.

Scientific Evidence:

  • Rozuvastatin is highly effective in reducing LDL cholesterol and triglycerides while increasing HDL cholesterol levels.
  • Research has demonstrated the cardiovascular benefits of rozuvastatin in reducing the incidence of major cardiovascular events.

Additional Information:

  • Follow a healthy diet and exercise regimen while taking Rozulip tablets to maximize benefits.
  • Regular monitoring of cholesterol levels is recommended to track treatment effectiveness.
  • Contact your healthcare provider immediately in case of any unusual symptoms or side effects.

Pharmacological Effects: Rozuvastatin works by inhibiting HMG-CoA reductase, reducing cholesterol production in the liver. This helps prevent plaque buildup in the arteries, lowering the risk of heart disease and stroke.

Clinical Trials: Rozulip (rozuvastatin) is superior to other statins in lowering LDL cholesterol levels and reducing cardiovascular event risks. Studies have shown its effectiveness in reducing atherosclerosis progression and improving cardiovascular outcomes.